Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
FOXO4-DRI (Proxofim) FOXO4-DRI (Proxofim) is a synthetic peptide studied for its ability to target senescent cells by disrupting FOXO4p53 interactions
After the deficiency is fixed, injections might be needed only once a month
You can also use the BPC-157 dosage calculator to determine precise amounts based on your vial concentration and target dose
This PK-PD disconnect is the defining feature of BPC-157s pharmacology
.webp)
To view or add a comment, sign in Ahead of the July 2026 Pharmacy Compounding Advisory Committee meeting, the FDA has released its scientific briefing documents
Resources and references This article summarizes published safety reports and clinical experience through 2024
US$ 26.51
US$ 21.32
US$ 21.80
US$ 24.21
US$ 22.55
US$ 27.85
US$ 25.66
